Fresh Recalls

FDAClass II · Drug · Recall D-0714-2026 · Recalled July 8, 2026

Gemcitabine Injection recall — McKesson

Agency report date: July 8, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Gemcitabine Injection
Company / brand
McKesson
Lot / serial / date codes
Lot #: CB0046, Exp. Date 06/2027
Distribution
Nationwide within the United States
Agency product description and boundaries

Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Gemcitabine Injection

3. Open the official notice or contact

Official recall ID
D-0714-2026
Brand
McKesson
Classification
Class II
Units affected
74 units
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Irving, TX, United States
Firm address
6555 State Highway 161, N/A, 75039-2402

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: CB0046, Exp. Date 06/2027
Distribution
Nationwide within the United States
Firm notified the public via
Telephone
FDA event ID
99262
Recall initiated
June 10, 2026
FDA classified
July 21, 2026
FDA report date
July 8, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page